| 000 | 01616 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514040729.0 | ||
| 264 | 0 | _c20020822 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000065060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGanjoo, Kristen N | |
| 245 | 0 | 0 |
_aA phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study. _h[electronic resource] |
| 260 |
_bOncology _c2002 |
||
| 300 |
_a299-304 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aGordon, Michael S | |
| 700 | 1 | _aSandler, Alan B | |
| 700 | 1 | _aWarner, Ruth E | |
| 700 | 1 | _aFife, Karen | |
| 700 | 1 | _aPoirier, Shelley | |
| 700 | 1 | _aSeshadri, Roopa | |
| 700 | 1 | _aLoehrer, Patrick J | |
| 773 | 0 |
_tOncology _gvol. 62 _gno. 4 _gp. 299-304 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000065060 _zAvailable from publisher's website |
| 999 |
_c12026164 _d12026164 |
||